Market Share of Hospital Infection Therapeutics Industry
The hospital infection therapeutics market is moderately fragmented in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including AbbVie Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., F. Hoffmann-La Roche AG, Bayer AG, GlaxoSmithKline plc, Aurobindo Pharma (Eugia), Sanofi, Pfizer, Inc., among others.
Hospital Infection Therapeutics Market Leaders
AbbVie Inc.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
F. Hoffmann-La Roche AG
*Disclaimer: Major Players sorted in no particular order
